Discover
WVE
Wave Life Sciences Ltd.
5.84
2 x 4.25
2 x 7.43
bid
ask
+
0.03
0.52%
2 @ 04:00 PM
5.80 -0.04 (0.68%)
| Ytd | -65.65% | |
| 1y | -10.43% |
5.79
day range
5.99
5.02
52 week range
21.73
| Open | 5.81 | Prev Close | 5.81 | Low | 5.79 | High | 5.99 | Mkt Cap | 1.12B |
| Vol | 3.12M | Avg Vol | 3.79M | EPS | -1.05 | P/E | N/A | Forward P/E | -5.39 |
| Beta | -1.33 | Short Ratio | 4.92 | Inst. Own | 82.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 6.45 | 200-d Avg | 9.72 | 1yr Est | 21.94 |
| Income Statement | |||
| Total Revenue | 38.25M | ||
| Revenues (USD) | 38.25M | ||
| Gross Profit | 38.25M | ||
| Operating Expenses | 69.54M | ||
| Research and Development Expense | 47.44M | ||
| Selling, General and Administrative Expense | 22.10M | ||
| Operating Income | -31.30M | ||
| Net Income | -26.09M | ||
| Net Income Common Stock | -26.09M | ||
| Net Income Common Stock (USD) | -26.09M | ||
| Consolidated Income | -26.09M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -26.09M | ||
| Earning Before Interest & Taxes (USD) | -26.09M | ||
| Weighted Average Shares | 200.17M | ||
| Weighted Average Shares Diluted | 200.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 544.59M | ||
| Cash and Equivalents (USD) | 544.59M | ||
| Investments | 3.82M | ||
| Investments Non-Current | 3.82M | ||
| Current Assets | 561.27M | ||
| Property, Plant & Equipment Net | 18.07M | ||
| Total Assets | 583.54M | ||
| Debt Current | 8.33M | ||
| Total Debt | 15.72M | ||
| Current Liabilities | 49.83M | ||
| Debt Non-Current | 7.39M | ||
| Total Liabilities | 71.81M | ||
| Accumulated Retained Earnings (Deficit) | -1.35B | ||
| Accumulated Other Comprehensive Income | -254.00K | ||
| Shareholders Equity | 511.73M | ||
| Shareholders Equity (USD) | 511.73M | ||
| Assets Non-Current | 22.27M | ||
| Total Debt (USD) | 15.72M | ||
| Deferred Revenue | 23.99M | ||
| Liabilities Non-Current | 21.98M | ||
| Trade and Non-Trade Payables | 19.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.31M | ||
| Net Cash Flow from Financing | 2.53M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -57.47M | ||
| Capital Expenditure | -438.00K | ||
| Issuance (Purchase) of Equity Shares | 2.53M | ||
| Net Cash Flow from Investing | -438.00K | ||
| Net Cash Flow from Operations | -59.55M | ||
| Effect of Exchange Rate Changes on Cash | -4.00K | ||
| Share Based Compensation | 9.06M | ||